Page last updated: 2024-09-04

levofloxacin and Hematologic Malignancies

levofloxacin has been researched along with Hematologic Malignancies in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's8 (61.54)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Bello, L; Caneiro, A; Gai, R; Galeano, S; Miller, A; Mosquera, R; Muxi, P; Oliver, AC; Pierri, S; Riva, E1
Barreto, JN; Dierkhising, RA; Gangat, N; Mara, KC; Tosh, PK; Yemm, KE1
Bilker, W; Bink, K; Fitzpatrick, R; Gilmar, C; Gorman, T; Han, JH; Kraus, K; Kucharczuk, C; Landsburg, D; Mangan, P; Moore, A; Pegues, D; Stadtmauer, EA; Ziegler, M1
Akashi, K; Aoki, T; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H1
Alonso, JM; Cantón, R; Cuartero, C; Del Campo, R; López, J; Lozano, S; Rodríguez, JD; Rodríguez-Domínguez, M; Ruiz-Garbajosa, P; Sánchez-Díaz, AM; Tedim, AP1
Abe, M; Araoka, H; Asano-Mori, Y; Hishinuma, A; Ishiwata, K; Izutsu, K; Kageyama, K; Kaji, D; Kimura, M; Nishida, A; Okamoto, Y; Takagi, S; Taniguchi, S; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A; Yoshida, A; Yuasa, M1
Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Park, GE; Peck, KR; Seok, HR; Song, JH1
Bellesso, M; Chamone, D; Costa, SF; Dorlhiac-Llacer, PE; Pracchia, LF; Santos Dias, LC1
Estes, LL; Wilson, JW; Zeuli, JD1
Dijstelbloem, Y; Huijgens, PC; Simoons-Smit, AM; Timmers, GJ; Touw, DJ; van Winkelhoff, AJ; Vandenbroucke-Grauls, CM1
Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I1
Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM1
Craig, M; Cumpston, AD; Devetten, MP; Ericson, SG; Hobbs, GR; Sarwari, AR1

Trials

3 trial(s) available for levofloxacin and Hematologic Malignancies

ArticleYear
Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Bone marrow transplantation, 2004, Volume: 33, Issue:8

    Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Digestive System; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Pharynx; Staphylococcus aureus

2004
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Penicillin V; Treatment Outcome; Viridans Streptococci

2007
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Bone marrow transplantation, 2007, Volume: 39, Issue:8

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Neutropenia; Ofloxacin; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous

2007

Other Studies

10 other study(ies) available for levofloxacin and Hematologic Malignancies

ArticleYear
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
    Annals of hematology, 2020, Volume: 99, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftazidime; Ciprofloxacin; Febrile Neutropenia; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Incidence; Levofloxacin; Male; Meropenem; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous; Uruguay; Young Adult

2020
A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult

2018
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Levofloxacin; Male; Middle Aged; Sepsis; Transplantation, Autologous

2019
Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Feces; Female; Hematologic Neoplasms; Host-Pathogen Interactions; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Treatment Outcome

2014
The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:1

    Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; beta-Lactam Resistance; Blood; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Molecular Typing; Neutropenia; Prospective Studies; Real-Time Polymerase Chain Reaction; Risk Assessment

2016
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    BMC infectious diseases, 2016, 08-05, Volume: 16

    Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospitals; Humans; Japan; Levofloxacin; Male; Middle Aged; Retrospective Studies; Streptococcal Infections; Transplantation Conditioning; Transplantation, Homologous; Viridans Streptococci; Young Adult

2016
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Intensive Care Units; Length of Stay; Levofloxacin; Male; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Respiratory Tract Infections; Risk Factors; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination

2016
Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
    Annals of hematology, 2011, Volume: 90, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Fever; Hematologic Neoplasms; Home Infusion Therapy; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Neutropenia; Ofloxacin; Retrospective Studies; Teicoplanin; Treatment Outcome

2011
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole

2013
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
    The new microbiologica, 2004, Volume: 27, Issue:3

    Topics: Anemia; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Hematologic Neoplasms; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections

2004